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                    1. INTRODUCTION         
 
 
India has become “the diabetes capital of the world” 1 and diabetes and its 
attendant complications are on the increase. Diabetic patients have an increased 
risk of getting infections especially urinary tract infections and asymptomatic 
bacteriuria is one of the leading forerunners to urinary tract infection.2,3,4  
Patients with diabetes have an increased risk of urinary tract infections 5,6. There 
is a roughly fivefold greater propensity toward urinary tract infections in diabetic 
women 7. Urinary tract infections are likely to be more severe in diabetic than 
nondiabetic women in terms of the complications involved 25 .Whether 
symptomatic urinary tract infections are preceded by asymptomatic bacteriuria 
(ASB) is a matter of debate .3,8,9     
Diabetic women have a higher prevalence of asymptomatic bacteriuria as 
compared to men and the prevalence has been found to increase with age. Most 
of the studies done on this condition have been in Europe and North America11 
and there are hardly any studies reported from India looking at the prevalence 
and associated risk factors for asymptomatic bacteriuria in the elderly diabetic 
population. 
The general recommendation is that asymptomatic bacteriuria is not to be 
treated12,13,14,15 and that screening for this condition and its treatment is 
necessary only in pregnant  women and people undergoing urethral procedures 
with a risk of mucosal injury . There are studies which show people with 
asymptomatic bacteriuria have a higher risk for subsequent urosepsis.4,16 
 8
 Hence this study was done among the diabetic out-patient population of a 
tertiary teaching care hospital in South India with a view of looking at potentially 
modifiable risk factors including cystopathy and bladder outlet obstruction to 
reduce the overall risk posed by this condition.  
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     2. AIMS AND OBJECTIVES OF THE STUDY 
 
 
 
AIM 
 
To study the prevalence and the clinical and the laboratory predictors of 
asymptomatic bacteriuria in older diabetic women.   
 
 
 
OBJECTIVE 
 
 
A) To estimate the prevalence of asymptomatic bacteriuria in elderly diabetic 
women.  
 
 
B) To assess if obstructive uropathy / diabetic cystopathy has an association with 
asymptomatic bacteriuria in older diabetic women. 
 
 
C) To assess if other clinical and laboratory factors such as HbA1C, duration of 
diabetes, body mass index etc have an association with asymptomatic 
bacteriuria in older diabetic women. 
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                3. REVIEW OF LITERATURE   
 
1. EPIDEMIOLOGY OF DIABETES MELLITUS   
 
The prevalence of diabetes mellitus in India has been growing by leaps and 
bounds17,18  . In the last twenty years there has been a three fold increase in the 
prevalence of diabetes 19,20 .The population of India is now more than 1000 
million and the estimate of the actual number of diabetics in India is around 40 
million21. India's diabetic population now ranks first in the world, even ahead of 
China although China’s total population is higher. This is because the prevalence 
of diabetes is far higher in India. It is estimated that by the year 2010 India will 
have nearly 20% of the world's diabetic population1. After a 10 to 15 years period 
of diabetes, the prevalence of all diabetes related complications increases 
markedly. The figure 1 below shows the estimated number of diabetic subjects in 
India.19,20      
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 2. DIAGNOSIS OF DIABETES MELLITUS 
A diagnosis of Diabetes mellitus can be made, according to American Diabetes 
Association (ADA) 2007 guidelines, if the blood sugar values fulfill any one of the 
following criteria22 :- 
 
ADA Criteria for the diagnosis of diabetes   
 
1. Symptoms of diabetes and a casual plasma glucose >/=200 mg/dl (11.1 
mmol/l). 
Casual is defined as any time of day without regard to time since last meal. The 
classic symptoms of diabetes include polyuria, polydipsia, and unexplained 
weight loss. 
OR 
 
2. FPG >/=126 mg/dl (7.0 mmol/l). Fasting is defined as no caloric intake for at 
least 8 h. 
OR 
 
3. 2-h plasma glucose >/=200 mg/dl (11.1 mmol/l) during an OGTT.  
The test should be performed as described by the World Health Organization, 
using a glucose load containing the equivalent of 75-g anhydrous glucose 
dissolved in water. 
 
 
Diagnosis of Impaired Fasting glucose 
Fasting glucose >100mg/dl and <126mg/dl 
 
 
Diagnosis of Impaired glucose tolerance 
2 hours postprandial glucose >140mg/dl and <200mg/dl. 
 
The 75 gm OGTT is more sensitive, more specific than fasting plasma glucose in 
diabetes but is poorly reproducible and rarely performed in practice.  
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3. URINARY TRACT INFECTIONS IN DIABETES MELLITUS   
 
Patients with diabetes have an increased risk of infections23, 24 with the urinary 
tract being the most prevalent infection site 5, 6. There is a roughly fivefold greater 
propensity toward urinary tract infections in diabetic women 7. Urinary tract 
infections are likely to be more severe in diabetic than nondiabetic women in 
terms of the complications involved 26 .Many urinary tract infections are 
asymptomatic and whether symptomatic urinary tract infections are preceded by 
asymptomatic bacteriuria (ASB) is a matter of debate 3, 8, 9 .      
 
4. ASYMPTOMATIC BACTERIURIA    
Half a decade ago routine quantitative urine culture for the microbiological 
diagnosis of urinary tract infections  was done by Kass and other 
investigators.10,26,138 Widespread acceptance and application of the quantitative 
urine culture identified several patient populations who were clinically 
asymptomatic but had a high prevalence of positive urine cultures 27 These 
included pregnant women, individuals with urological abnormalities, patients with 
indwelling urethral catheters, elderly individuals and diabetics. The prevalence of 
asymptomatic bacteriuria varies in different age groups and also population 
groups. It is higher in the older population, non ambulant people, people with 
indwelling urinary catheters and people practicing intermittent clean self 
catheterisation .The values of prevalence in different people groups are shown in 
the table in the next page.  
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Table 1. Prevalence of Asymptomatic bacteriuria in selected populations 
 
Population     
 
Prevalence (%) 
 
Healthy premenopausal women28 
 
1.0 to 5.0 
 
Pregnant women28 
 
1.9 to 9.5 
 
Post menopausal women(50-70 years) 28 
 
2.8 to 8.6 
 
Patients with diabetes 
 
   
         Women13 
 
9.0 to 27.0 
        
         Men13 
 
0.7 to 1.0 
 
Older community dwelling patients 
 
       
        Women (> 70 years) 28 
 
>15.0 
         
        Men13 
 
3.6 to 19.0 
 
Older long- term care residents 
 
        
        Women13 
 
25.0 to 50.0 
       
        Men13  
 
15.0 to 40.0 
 
Patients with spinal cord injuries 
 
        
        Intermittent catheter29 
 
23.0 to 89.0 
       
        Sphincterotomy and condom catheter30 
 
57.0 
 
Patients undergoing haemodialysis31 
 
28.0 
 
Patients with indwelling catheter 
 
        
        Short term32 
 
9.0 to 23.0 
       
        Long term32   
 
100 
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5. DEFINITION OF ASYMPTOMATIC BACTERIURIA 
Asymptomatic bacteriuria also referred to as asymptomatic urinary tract 
infection28   is defined as the presence of at least 105 colony-forming units 
(cfu)/ml of one or two bacterial species in a clean-voided midstream urine 
sample from individuals without symptoms of a urinary tract infection.  
According to Infectious Disease Society of America guidelines 2005 33   the 
diagnosis of asymptomatic bacteriuria in women is appropriate only if the same 
species is present in quantities of at least 105  cfu/mL of urine in at least two 
consecutive voided specimens. Alternative definitions have been used in some 
studies. Bacteriuria has been identified with only a single specimen 2, or requiring 
as many as three consecutive specimens with consistent microbiological 
results34. Studies that define bacteriuria with only a single voided specimen report 
a higher prevalence of asymptomatic bacteriuria then those requiring persistent 
bacteriuria from two or more specimens. For men, a single voided specimen with 
a quantitative count of a potential uropathogen of >/= 105  cfu/mL is sufficient to 
diagnose bacteriuria35  
For any asymptomatic patient, bacteriuria is also defined as a single catheterized 
urine specimen with one bacterial species isolated in counts >/= 102 cfu/ml. 
Though a count of >/= 102 cfu/ml has been validated in research settings to be 
significant, many clinical laboratories do not routinely quantify counts in these 
range. 
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6. SCREENING FOR ASYMPTOMATIC BACTERIURIA 
  
 
Unless the person is symptomatic screening for asymptomatic bacteriuria is not 
recommended except in the second trimester of pregnancy (12-16 weeks gestation) 
36 or if the person needs to undergo an urological procedure with risk of having a 
mucosal injury. The Infectious Disease Society of America Guidelines 2005 
recommendations for asymptomatic bacteriuria in adults are summarized in the 
table 2 and 3 below.33
   
 
Table 2. IDSA Recommendations for screening for, and treatment of, 
asymptomatic bacteriuria (ASB) 33  
Recommendation Grade 
Pregnant women should be screened for bacteriuria by urine culture at least once in 
early pregnancy, and they should be treated if the results are positive 
A-I 
Screening for ,and treatment of ,ASB before transurethral resection of the  prostrate is 
recommended 
A-I 
Screening for ,and treatment of ,ASB is recommended before other  urological 
procedures for which  mucosal bleeding is anticipated 
A-III 
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Table 3. IDSA Recommendations against screening for, and treatment 
of, asymptomatic bacteriuria 33 
Recommendation                                                                                          Level          
1.Premenopausal ,non pregnant women A-I 
2.Diabetic women A-I 
3.Older people living in the community A-II 
4.Elderly,institutuionalized people A-I 
5.People with spinal-cord injury A-I 
6.Patients with indwelling catheters A-I 
Strength of recommendation  
‘A’ means the recommendation is always valid. 
‘B’ that it is valid in most cases. 
‘C’ it may or may not be appropriate. 
Quality of evidence is judged by Roman Numericals. 
‘I’ for at least one prospective randomized comparative trial. 
‘II’ for prospective cohort studies or case control studies. 
‘III’ for consensus of experts in the absence of appropriate clinical trials. 
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7 .SCREENING TESTS FOR ASYMPTOMATIC BACTERIURIA 
Other tests for asymptomatic bacteriuria which have been used for screening 
purposes are: 
1. Nitrite test  
2. Leukocyte esterase test. 
 Urinary nitrite tests for asymptomatic bacteriuria have 43% sensitivity and 99% 
specificity. Urinary leukocyte esterase test for asymptomatic bacteriuria has 77% 
sensitivity and 96% specificity. Screening tests for asymptomatic bacteriuria using 
both nitrite and leukocyte esterase tests combined have 92% sensitivity and 95% 
specificity. 37,38 
 
8. PATHOPHYSIOLOGY OF ASYMPTOMATIC BACTERIURIA 
The presence of bacteria in the absence of a major inflammatory response points to 
a subtle disturbance of the host –parasite interaction39. The microbiology of 
asymptomatic bacteriuria is similar to that of cystitis and pyelonephritis .Some 
bacterial strains with reduced capability for fimbrial expression appear to have the 
capability of relatively rapid growth thus causing asymptomatic bacteriuria. 40 
Alternatively strains implicated in asymptomatic bacteriuria may be less virulent and 
therefore may not necessarily be true pathogens41, 42, 43. Potential host factors may 
also be responsible for the absence of symptoms. A study of children with 
asymptomatic bacteriuria demonstrated lower levels of neutrophil Toll –like receptor 
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(TLR4) expression compared to age matched controls.44 One study in which 
granulocyte function was tested in women with diabetes and asymptomatic 
bacteriuria found no difference in function as compared to non bacteriuric and 
healthy control subjects. 45   
The bacteriology of asymptomatic UTI is similar in diabetic and nondiabetic women 
with the preponderance being caused by Escherichia coli and other gram-negative 
organisms. 
 
9. CONSEQUENCES OF ASYMPTOMATIC BACTERIURIA IN 
DIABETES MELLITUS 
Asymptomatic bacteriuria in diabetes mellitus identifies a group at risk for 
subsequent severe urinary tract infections 16,46,47 .In one study a large cohort of 
diabetic women in the Netherlands was studied to determine the incidence of 
symptomatic UTIs 4 .In women with type 2 diabetes (but not with type 1), the 
presence of asymptomatic bacteriuria at baseline increased the risk of subsequent 
symptomatic UTI in the 18 month follow-up period from 19 to 34 percent. The rate 
of asymptomatic bacteriuria in this population was approximately 28 percent. By 
contrast, incidence of asymptomatic UTI was 6 percent in women who were not 
diabetic but attended other clinics in the same institution 11.  
 In another prospective observational study 496 adults with type 1 or 2 diabetes 
were followed for 2.9+/-0.6 years for hospital admission for/with urosepsis or death. 
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Of them thirty-six patients (7.3%) had ASB, comprising 33 females (14.4% of all 
females) and three males (1.1% of all males). Only female sex predicted ASB 
amongst a range of variables including indices of metabolic control. Twenty-nine 
patients (5.8%) were subsequently hospitalized with urosepsis. Of these, urosepsis 
was the principal diagnosis in 12 (41%).Diabetics with ASB were 4.4 times more 
likely to be hospitalized with urosepsis as principal diagnosis as compared to 
diabetics without ASB (hazard ratio 4.4[95% CI]  [1.2-16.5]; p=0.004).   
Thus the presence of ASB identifies a group of diabetic patients who are at 
significantly increased risk of subsequent urosepsis requiring hospitalization. 
However there is a consensus that in the absence of anatomical or functional 
abnormalities of the urinary tract, ASB per se does not lead to renal scarring, renal 
dysfunction, or hypertension48.  A 14 year follow up of asymptomatic and 
symptomatic diabetic patients was done to look at the natural history of untreated 
asymptomatic bacteriuria .It was found that the clinical symptoms of acute 
pyelonephritis occur with similar frequency in both groups and there was no 
deterioration of kidney function was found and the occurrence of arterial 
hypertension did not differ significantly in both groups at the beginning and end of 
the follow-up.49 
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10. RISK FACTORS FOR ASYMPTOMATIC BACTERIURIA  
A prospective study which evaluated 796 sexually active, nonpregnant women 
from 18 through 40 years of age over a period of six months for the occurrence of 
asymptomatic bacteriuria concluded that asymptomatic bacteriuria was 
associated with the same risk factors as for symptomatic urinary tract infection, 
particularly the use of a diaphragm plus spermicide and sexual intercourse2. 
Genetic factors may also be involved. One Canadian study showed a higher rate 
of asymptomatic UTI in aboriginal diabetic women than in diabetic women of 
European heritage 50   
In Type 2 Diabetes Factors that have correlated with asymptomatic bacteriuria 
are female sex, urinary incontinence, leukocyturia, and elevated C reactive 
protein concentration. 47,51  
A prospective cohort study of 218 diabetic and 799 nondiabetic postmenopausal 
women examined risk factors for asymptomatic bacteriuria and UTI 51. Increased 
risk occurred mainly in women taking insulin (relative risk 3.7) and those with a 
longer diabetes duration (>10 years, relative risk 2.6) but not in those with poor 
glucose control. Women with diabetes and bacteriuria are characterized by a 
more prolonged duration of diabetes and long-term complications such as 
neuropathy, but not by abnormal parameters of diabetic control, such as 
glycosylated haemoglobin. 50  
It has not been universally agreed that asymptomatic bacteriuria poses risks. In 
another study in order to compare the incidence of symptomatic UTI in diabetic 
patients with and without asymptomatic bacteriuria (ASB), and to identify other 
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risk factors for these infections, 289 females and 168 males were studied over a 
12-month period52. Symptomatic UTI occurred in 69.2% of patients with ASB 
(67.6% female and 76.5% male) versus 9.8% without ASB (14.9% female and 
2.6% male). ASB and urinary incontinence were associated with symptomatic 
UTI in both women and men. Other risk factors included previous antimicrobial 
treatment and macrovascular complications in women and obesity and prostatic 
syndrome in men. The presence of ASB was found to be the major risk factor for 
developing symptomatic urinary tract infection. 
 
11. ASYMPTOMATIC BACTERIURIA IN DIABETIC WOMEN 
Asymptomatic bacteriuria may be considered as a complication in women with 
diabetes11. In contrast with men, a higher incidence of asymptomatic bacteriuria 
has been found in women with diabetes than women without the disease. 
6,8,9,53,54,141 
The relevance of asymptomatic bacteriuria in diabetic women stems from the 
following factors: 
 There is a roughly fivefold greater propensity toward urinary tract infections in 
diabetic women 7. Urinary tract infections are likely to be more severe in diabetic 
than nondiabetic women in terms of the complications involved 25 . Asymptomatic 
bacteriuria often precedes symptomatic urinary tract infections in type 2 diabetes. 3 
The best estimate is an approximately three- to fourfold increase in risk of 
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asymptomatic bacteriuria in diabetic women compared to non diabetic women (18 
versus 6 percent 50, 26 versus 6 percent 55.   
 
12 .ASYMPTOMATIC BACTERIURIA IN THE ELDERLY 
POPULATION   
Asymptomatic bacteriuria in the elderly is associated with a significant proneness to 
infection56. One study showed it was associated with a reduction in survival of 30 to 
50 per cent.57The prevalence of ASB in the elderly ranges from 17 to 50 % in 
women, and 6-34% in men. It increases with advancing age and the level of 
disability. Elderly people living at home are less likely to have bacteriuria than those 
living in long term care facilities .In the absence of urinary obstruction, ASB in the 
elderly does not lead to renal failure or hypertension.   
Majority of studies done show that there is no role for screening for or treatment of 
asymptomatic bacteriuria among older persons in the community33 as these 
patients are not at increased risk for adverse outcomes related to asymptomatic 
bacteriuria29,58-62. This was also brought out in a randomized controlled trial of 
antibiotic therapy for 124 elderly ambulatory women with asymptomatic bacteriuria 
58. There was no significant difference in the number of symptomatic episodes 
during the six-month follow-up period. In addition, bacteriuria is transient and tends 
to recur after therapy, with emergence of antibiotic resistance 33. 
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There is also no role for screening for or treatment of asymptomatic bacteriuria 
among the elderly in health care facilities 33. Although half of women and 15 to 40 
percent of men have asymptomatic bacteriuria 29, antimicrobial treatment has not 
been shown to be of benefit. This was illustrated in a study of 191 nursing home 
residents with incontinence and bacteriuria who were randomly assigned to 
immediate or delayed treatment 63. Eradicating bacteriuria had no short-term 
effects on the severity of chronic urinary incontinence. In addition, bacteriuria 
tends to recur after therapy, with emergence of antibiotic resistance. 
In conclusion attempts to obtain sterile urine in the elderly with prolonged 
antimicrobial treatments appear to be futile due to high rates of infection. In 
addition, no differences in morbidity and mortality were seen when antimicrobial 
therapy was given. Thus in the absence of urological abnormalities, ASB is a 
benign condition that does not require antibiotic treatment.  
13. ASYMPTOMATIC BACTERIURIA AND OBSTRUCTIVE 
UROPATHY 
Is obstructive uropathy associated with higher incidence of asymptomatic 
bacteriuria? There is a paucity of literature or studies regarding this association. 
Such studies would be relevant due to the high prevalence of obstructive 
uropathy among the elderly and also especially in long term diabetics.    
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14. PYURIA AND ASYMPTOMATIC BACTERIURIA 
 
Pyuria is often a common accompaniment of asymptomatic bacteriuria. The 
presence of asymptomatic bacteriuria and pyuria varies in different population 
groups. Pyuria is accompanied by a greater prevalence of asymptomatic 
bacteriuria. 
Pyuria causes an increased prevalence of asymptomatic bacteriuria but has no 
prognostic significance and hence should not influence decisions about 
antimicrobial therapy. 64-66 
Table 4. Prevalence of ASB in different populations with or 
without pyuria.    
  
Population                          ASB(%)  in 
patients 
without  
pyuria      
ASB (%) in patients 
with  pyuria       
 
Healthy adult women2 
 
2--5 
 
32 
 
Pregnant women67 
 
2--11 
 
50 
 
Diabetic women50 
 
7--9 
 
70 
 
Elderly : nursing home29  
 
5--50 
 
90 
 
Spinal cord injury patients30 
 
50 
 
33--86 
 
Indwelling urethral catheter68 
 
100 
 
70 
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15. GUIDELINES FOR THE TREATMENT OF ASYMPTOMATIC 
BACTERIURIA  
A common dilemma in clinical medicine is whether to treat asymptomatic patients 
who present with bacteria in their urine140. Several studies have shown that, while 
treatment of asymptomatic bacteriuria is effective in eliminating the bacteria from 
the urine, the benefit does not persist. Thus antibiotic therapy does not reduce 
subsequent reinfection causing asymptomatic bacteriuria 69. Moreover treatments 
with antibiotics have increased the incidence of resistant organisms which are more 
dangerous. Treating asymptomatic bacteriuria in diabetic women is not 
recommended based upon multiple studies which have not demonstrated improved 
outcomes with therapy139. 
 The best data come from a prospective trial in which 105 diabetic women over the 
age of 16 years with asymptomatic bacteriuria were randomly assigned to 14 days 
of antibiotics or placebo12.  At four weeks after the end of therapy, a significantly 
greater proportion of patients in the antibiotic group cleared the bacteriuria (80 
versus 22 percent with placebo). After this six week period, the group assignment 
was revealed, and patients were followed for a mean of 27 months; bacteriuria was 
assessed at three month intervals and patients who originally received antibiotics 
were treated during subsequent episodes. Patients were also evaluated for 
symptomatic UTI, pyelonephritis, and hospitalization for UTI. There were no 
significant differences between the groups in the development of a symptomatic 
UTI, the timing of onset of such an infection or any of the other parameters. 
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 Patients in the antibiotic treatment group had nearly five times the number of days 
on antibiotics compared to the placebo group. However, as in the subgroups 
described above, antibiotic therapy for asymptomatic bacteriuria does not affect the 
frequency of or time to symptomatic infection (including pyelonephritis), reinfection 
is common, and long-term prognosis is not improved. 12-15   
16. UROLOGICAL COMPLICATIONS OF DIABETES MELLITUS  
Diabetes and urological diseases are very common health problems that markedly 
increase in prevalence and incidence with advancing age 70-72. Diabetes is 
associated with an earlier onset and increased severity of urologic diseases, 
resulting in costly and debilitating urologic complications. Urologic complications 
including bladder dysfunction, sexual and erectile dysfunction, as well as urinary 
tract infections, have a profound effect on the quality of life of women with 
diabetes.73  
Over 50% of men and women with diabetes have bladder dysfunction 74, 75. 
Diabetes has been identified as an important independent risk factor for 
incontinence in several large observational studies, including the Nurses’ Health 
Study, and is associated with 30–100% increased risk76-79.  Other aspects of 
diabetes severity, including glycaemic control and microvascular complications 
resulting in damage to innervation of the bladder, have been suggested as possible 
mechanisms for increasing incontinence 80. Questions remain as to whether there is 
any association between bladder dysfunction and urinary incontinence in relation to 
asymptomatic bacteriuria in diabetics. The methods used to document the 
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urological associations of asymptomatic bacteriuria in diabetics include 
uroflowmetry and post voidal residual urine and urodynamic studies.      
17. UROFLOWMETRY 
Uroflowmetry is the study of the flow of the urine from the urethra81. It is the 
noninvasive determination of the characteristics of urine flow. Urine flow is 
described in terms of rate and pattern and may be continuous or intermittent82 
Urinary flow rate determined is thus the product of the final result of the act of 
voiding and is influenced by the variables - detrusor pressure, urethral patency 
and sphincter relaxation. Because all three variables influence the uroflow, 
uroflometry cannot be used to establish a diagnosis, but, when combined with 
measurement of residual urine it provides a rapid and economic screening tool 
for the effectiveness of the act of voiding. Patients with abnormal uroflow require 
more detailed evaluation to further elucidate the cause of their voiding problem. 
The patient who presents for an uroflowmetry study should be well hydrated with 
a reasonably full bladder. An overly distended bladder may cause temporary 
detrusor compensation resulting in a lower than normal flow rate. The study 
should be performed in relative privacy and the patient should be encouraged to 
void in as normal a fashion as possible. It is important to obtain a flow that is 
representative of the patients’ usual flow and the patient should be asked about 
this .If there is any doubt the test should be repeated 82. 
The normal uroflow curve is plotted with the flow rate on the Y axis (ml/sec) and 
time on the x axis (sec). The precise shape of the flow curve is decided by 
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detrusor contractility, the presence of any abdominal straining and by the bladder 
outlet. 83 
 The flow pattern that is the shape of the flow tracing can sometimes be used to 
make a presumptive diagnosis although it cannot be used to make a definitive 
diagnosis. The normal flow pattern is a continuous bell shaped smooth curve with 
a rapidly increasing flow rate. An intermittent flow pattern is one that has one or 
several episodes of flow increasing or decreasing (or ceasing completely) and is 
more commonly secondary to abdominal straining or external sphincter spasm 
(e.g. detrusor sphincter dyssynergia).The typical obstructed flow pattern has a 
plateau-shaped curve with a prolonged flow time ,sustained low flow state and 
increased  time to Qmax. But this is not diagnostic of outlet obstruction because 
detrusor hypocontractility can have a similar tracing. 
 
The International Continence Society has recommended the following definitions 
for the evaluation of uroflometry 84. 
 
Flow rate is defined as the volume of fluid expelled via the urethra per unit time.  
It is expressed in ml/s. The normal flow rate from a full bladder is about 20-25 
mL/s in men and 25-30 mL/s in women. These variations are directly related to 
the volume voided and the person’s age. Obstruction should be suspected in any 
adult voiding with a full bladder at a rate of less than 15 mL/s. A flow rate less 
than 10 ml/s is considered definite evidence of obstruction. Lower flow rates 
suggest bladder outlet obstruction or  weak detrusor contractility 85 .Moreover a 
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normal flow maybe seen in patients with urethral obstruction if they generate 
detrusor pressure high enough to overcome the increased urethral 
resistance.86To distinguish between obstruction and impaired detrusor 
contractility it is necessary to measure detrusor pressure and uroflow  
simultaneously64,85,88-90 
Table 5.Utility of Maximal urinary flow rate (Qmax) for diagnosis  
of bladder outlet obstruction 91        
 Threshold Q max    
             (ml/sec)            
<10                  <15 
Sensitivity 
Specificity 
Positive predictive value 
1-negative predictive value 
47% 
70% 
70% 
54% 
82% 
38% 
67% 
42% 
 
 
 Higher flow rates suggest bladder spasticity or excessive use of abdominal 
muscles to assist voiding. Intermittent flow patterns generally reflect spasticity of 
the sphincter or straining to overcome resistance in the urethra. 
 
Some of the terminologies used in urodynamics and lower urinary tract 
symptoms are shown in Figure2: 
Voided volume is the total volume of urine expelled through the urethra.  
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Maximum flow rate (Q max) is the maximum measured value of the flow rate 
(the peak of the flow curve) after correction for artifacts  
 
Voiding time is total duration of micturition, i.e. includes interruptions.  When 
voiding is completed without interruption, voiding time is equal to flow time.   
  
Flow time is the time over which measurable flow actually occurs.   
 
Average flow rate is voided volume divided by flow time.  The average flow 
should be interpreted with caution if flow is interrupted or there is a terminal 
dribble.   
Time to maximum flow is the elapsed time from onset of flow to maximum flow.  
 
           
          Figure 2. Graphical representation of uroflowmetry 
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Peak flow rate is generally the most reliable in detecting abnormal voiding. 
It is influenced by several factors. 
1. Age and sex. 
In men, Qmax decreases with age, whereas in women it is not influenced by 
age92 Normal women have a higher flow rates for a given voided volume than 
age matched men. It is likely related to lower outlet resistance. 
 
Normal values for Qmax are given in the table 6 below  
      Table 6.Normal values for uroflowmetry 93  
Gender  Age(years) Peak Flow rate(ml/sec) 
Males <40 
40-60 
>60 
>22 
>18 
>13 
Females <50 
>50 
>25 
>18 
 
2. Chance. 
It has been documented that 40% of men have a difference in Q max of at least 2 
ml/sec between voids94and 20 % of men may have a difference of at least 4 
ml/sec95 .Thus it has been recommended by some that multiple flow rates be 
recorded to increase the likelihood that a representative flow is achieved137. 
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3. Voided volume. 
The volume voided probably has the greatest effect on peak flow rate, and it is 
generally accepted that voided volumes of less than 150 ml generate inaccurate 
flow patterns and parameters96,97.  The third International Consultation on Benign 
Prostatic Hypertrophy (1995 ) recommends that at least 2 uroflow measurements 
be taken with at least 150 ml voided each time when performing uroflowmetry. 
The ICS-BPH study mentions that voids of less than 150 ml can provide useful 
information (particularly in truly obstructed patients) and thus should not be 
discarded98.   
The initial intravesical volume is the predominant factor affecting Qmax.87  
 
18. RESIDUAL URINE 99  
 
Residual urine [post void residual (PVR) urine] is defined as the volume of fluid 
remaining in the bladder immediately following the completion of micturition. A 
post void residue of less than 50 ml is considered normal, and a post void 
residue of more than 200 ml is considered abnormal. Values between 50 - 200ml 
requires clinical correlation.100   
The measurement of residual urine forms an integral part of the study of 
micturition. However voiding in unfamiliar surroundings may lead to 
unrepresentative results, as may voiding on command with a partially filled or 
overfilled bladder. 
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 Residual urine is commonly estimated by the following methods: 
(a) Catheter or cystoscope (transurethral, suprapubic). 
(b) Radiography (excretion urography, micturition cystography). 
(c) Ultrasonics. 
(d) Radioisotopes (clearance, gamma camera).   
 
When estimating residual urine the measurement of voided volume and the time 
interval between voiding and residual urine estimation should be recorded: this is 
particularly important if the patient is in a diuretic phase. In the condition of 
vesicoureteric reflux, urine may re-enter the bladder after micturition and may 
falsely be interpreted as residual urine. The presence of urine in bladder 
diverticula following micturition presents special problems of interpretation, since 
a diverticulum may be regarded either as part of the bladder cavity or as outside 
the functioning bladder. The various methods of measurement each have 
limitations as to their applicability and accuracy in the various conditions 
associated with residual urine. Therefore it is necessary to choose a method 
appropriate to the clinical problems. The absence of residual urine is usually an 
observation of clinical value, but does not exclude infravesical obstruction or 
bladder dysfunction. An isolated finding of residual urine requires confirmation 
before being considered significant. Furthermore the tests should be repeated 
because the test retest reliability of post void residual measurements is poor 101.     
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19. BLADDER OUTLET OBSTRUCTION 
 
This is the generic term for obstruction during voiding and is characterized by 
increased detrusor pressure and reduced urine flow rate. Bladder outlet 
obstruction is usually diagnosed by studying the synchronous values of flow rate 
and detrusor pressure.  
There are no universally accepted urodynamic criteria for the diagnosis of female 
bladder outlet obstruction; although some have defined it based on urodynamic 
parameters.102 Bladder outlet obstruction in women is an infrequently diagnosed 
urological condition for several reasons. Often it is not suspected .Women have 
fewer reported classic obstructive symptoms, like poor flow, hesitancy and 
stranguria, than men, probably in part because they are frequently poor 
historians with respect to the force of the urinary stream, since they void in 
private and have little opportunity to compare voiding patterns. Women 103,104 
commonly present with irritative symptoms of urinary frequency, urgency, urge 
incontinence and recurrent urinary tract infections 105,106    
As there are no universally accepted urodynamic criteria for the diagnosis of 
female bladder outlet obstruction, others have used Urodynamic Parameters in 
an attempt to define it. 105-107 Normograms for diagnosing bladder outlet 
obstruction in men, cannot be applied to women. Voiding dynamics are different 
in women, as many void with low detrusor pressure or by relaxing pelvic floor 
muscles. Some women by habit augment voiding by abdominal straining. Since 
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normal voiding detrusor pressure is significantly lower in women than in men, it is 
reasonable that voiding pressures used to define obstruction would also be 
different. Carr et al highlighted the difficulties of diagnosing female bladder outlet 
obstruction based on history, physical examination and common diagnostic tests 
108 Therefore, a high index of suspicion and better criteria to define obstruction in 
women are needed so that clinicians can accurately diagnose and treat the 
different causes of female bladder outlet obstruction. Chancellor et al has stated 
that conceptually bladder outlet obstruction may be defined by a detrusor 
contraction of adequate magnitude, duration and speed, and a low urine flow. 88   
 
20. BLADDER DYSFUNCTION IN DIABETES MELLITUS  
 
Bladder dysfunction has been recognized as a frequent complication of diabetes 
mellitus, and has been characterized by impaired bladder sensation, increased 
bladder capacity and decreased bladder contractility, resulting in increased 
residual urine, urinary retention or overflow incontinence 109   . 
Experimental diabetic animals similarly exhibited bladder dysfunctions, such as 
increased threshold volume for reflex bladder contraction and altered detrusor 
contractility 110.The cystopathic findings in diabetic animals were reportedly 
associated with changes at various levels, including bladder innervating sensory 
and autonomic pathways and/or the detrusor muscle. 111 Since clinical studies 
revealed that diabetic neuropathy, such as gastro paresis, abnormal sweating or 
orthostatic hypotension, was often found in patients with diabetic cystopathy, it 
has been generally admitted that peripheral neuropathy has an important role in 
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diabetic cystopathy. 112 However, the underlying mechanisms inducing bladder 
dysfunction in diabetes remain controversial. 
The normal value for bladder sensation or capacity varied among studies. 113-116 
.Bladder dysfunctions was found in 36% of 53 patients investigated when it was 
defined as an increase in bladder capacity to more than 400 ml. with a flat trace 
on cystometrography according to the criteria proposed by Kahan et a1. 113 Using 
the criterion that bladder capacity exceeding 500 ml. was regarded as abnormal 
116,117. 32% of patients in one study had diabetic cystopathy. Thus calculated 
incidences are not different from the 30 to 80% rates in other clinical studies. 79 
Frimodt-Moller first reported detailed characteristics of bladder dysfunction, such 
as loss of bladder sensation and increased bladder capacity, in unselected 
diabetic patients. 114 In that series diabetic cystopathy was characterized as loss 
of sensation detected by elevated electrical bladder perception threshold, and it 
was found in 38% of 100 unselected diabetic patients. 
 
A short history or early stage of diabetes does not exclude the existence of 
diabetic cystopathy, since bladder dysfunction was observed in patients with 
diabetes for less than 12 months, no retinopathy or treatment by diet only118. The 
same study from Japan also demonstrated presence of bladder dysfunction in 
patients without voiding symptoms. Kaplan et al reported that the etiology of 
voiding dysfunction in diabetic patients with persistent voiding symptoms was 
attributable not only to classic diabetic cystopathy but also to other 
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pathophysiological conditions, including bladder outlet obstruction or detrusor 
hyperreflexia79.  
Autonomic neuropathy detected by the sympathetic skin response coexisted with 
bladder dysfunction in a significant percentage of diabetic patients. It has been 
demonstrated that the sympathetic skin response is a simple and valuable test to 
subjective symptoms alone 118.In conclusion bladder dysfunction is observed in 
diabetic patients with and with out subjective voiding symptoms when examined 
urodynamically. 
 
 
21. DIABETIC CYSTOPATHY 
 
Diabetic cystopathy is thus a chronic complication of diabetes which is insidious 
in onset, characterized by increased length of time between voiding .It has 
received less attention as compared to diabetic nephropathy although it affects 
day-to-day life. Prevalence is estimated to be between 32% to 45%.109, 119 
The classic triad of bladder symptoms associated with Diabetic Cystopathy (DC) 
includes decreased bladder sensation, increased bladder capacity, and impaired 
detrusor contractility103 with resultant increased post void residual (PVR) urine 78. 
Increased PVR leaves the individual prone to urinary tract infections (UTIs), a 
common cause of acute confusion and functional decline in older adults. A 
possible link between deterioration of renal function and chronic asymptomatic 
bacteriuria in individuals with diabetes has been postulated.4  
Increasingly, diabetic cystopathy is described as a manifestation of autonomic 
neuropathy, 119,120 although some believe it also represents peripheral somatic 
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neuropathy. 121 Several classification systems for diabetic neuropathy have been 
suggested, but none has included specific lower urinary tract function. Greene, 
Stevens, and Feldman122 proposed that genitourinary neuropathy fits within the 
autonomic neuropathy category, along with sudomotor, cardiovascular, and 
gastrointestinal neuropathies. Autonomic neuropathies are serious and 
irreversible complications of diabetes.  
Mechanism of diabetic cystopathy 
Autonomic neuropathies in diabetes result in axonal degeneration, 
demyelination, and fiber loss. Hyperglycemia has been implicated as a primary 
contributor to development of neuropathic complications. Tight control of blood 
glucose decreases long-term neurological and microvascular complications of 
diabetes, 123 but the precise relationship of glycaemic control and duration of 
diabetes to diabetic cystopathy is not known. One possible mechanism of 
glucotoxicity in nervous tissue is increased polyol pathway activity in which 
accumulations of sorbitol and fructose induce damage. The exact mechanism of 
damage has not yet been elucidated. 124,125  
Other possible contributors to diabetic nerve damage include immune 
mechanisms, microvascular insufficiency, deficiency of growth factor, and 
decreased expression of laminin, a glycoprotein important in nerve 
regeneration.121  
 
Because diabetic cystopathy is a manifestation of autonomic neuropathy, 
screening for other signs of autonomic dysfunction may be included, particularly 
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heart rate and orthostatic hypotension assessment measured by blood pressure 
while the patient is lying and standing. It is not clear whether cardiovascular 
autonomic neuropathy occurs with or progresses at the same rate as diabetic 
cystopathy, but the presence of cardiovascular dysautonomia may identify other 
problems that need to be addressed. Because one of the hallmarks of diabetic 
cystopathy is an increase in residual urine, the PVR should be measured either 
by portable ultrasound or in-and-out catheterization. Ideally, PVR should be 
measured within minutes of voiding. Norms for acceptable levels of PVR have 
not been established. One suggested normal range in the older adult is between 
50 mL and 150 mL. 126 
Little research has been published to guide practice in diabetic cystopathy 
management. Evidence is modest at best for all interventions except glycaemic 
control. Preventing further diabetes associated neuropathy is an important goal in 
modifying or eliminating risk factors. Other management goals include symptom 
relief, infection prevention, renal function maintenance, continence, and 
adequate bladder emptying. 78  
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Table  7 . Management strategies for diabetic cystopathy 127 
 
Glycaemic control 
 
 
Diet, exercise, weight loss 
Oral glucose lowering agents 
Insulin stimulators (secretagogues) 
Sulfonylurea  
Meglitinides  
Insulin sensitizers 
Biguanides  
Thiazolidinediones  
Alpha glucosidase inhibitors 
Insulin 
 
 
Voiding Strategies 
 
 
Scheduled toileting 
Follow up PVR measurement needed to assess 
bladder emptying 
Double voiding 
Bladder expression 
Use only if urodynamics demonstrate no 
vesicoureteral reflux 
 
 
Catheterization 
 
 
Intermittent catheterization (if voiding strategies 
ineffective) 
Indwelling catheterization (last resort) 
 
 
Nocturnal polyuria 
 
 
Fluid management: avoid caffeinated beverages at 
night, take most of fluids during the day 
Empty bladder before going to bed 
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Advising patients to void every two to four hours during the day and to use a 
double voiding technique may improve bladder emptying, improve continence, 
and minimize risk of infection. Because diabetic cystopathy is of gradual onset, it 
may be useful to encourage the diabetic client to begin this habit even if the PVR 
is below 150 mL. Double voiding involves attempting to empty the bladder by 
staying on the toilet and trying to void more than once with each trip to the toilet. 
Elders with cognitive impairment might need supportive cuing from caregivers to 
carry out the strategy. These noninvasive strategies are worth trying, although 
their effectiveness has not been studied. Teaching these strategies should be 
followed with periodic measurement of PVR in patients with elevated residual 
urine to ensure that adequate bladder emptying is achieved. No effective 
medications currently are available to assist with bladder emptying in diabetic 
cystopathy. Bethanechol, a parasympathomimetic agent, has been used with 
inconsistent results. 128 Research on agents such as aldose reductase inhibitors, 
which inhibit the accumulation of sorbitol and fructose to potentially improve 
neuropathy, advanced glycosylation end product, and neurotrophic factors may 
lead to future treatment options. 128                
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                  4. MATERIALS AND METHODS   
 
Setting 
107 older diabetic women who satisfied the inclusion criteria were recruited from 
the outpatient clinics of the Department of Medicine and the Department of 
Endocrinology of the Christian Medical College Hospital Vellore, a 2200 bedded 
tertiary care teaching hospital in South India.   
Duration of Study            
October 2007 to August 2008. 
Inclusion criteria          
Female subjects were included in the study if they were ambulant, had Type 2 
diabetes mellitus, were above 50 years of age and gave written voluntary 
consent to take part in the study. 
Exclusion criteria        
1. Patients with features of lower urinary tract infection (i.e: dysuria with 
increased frequency or dysuria with urgency or dysuria with fever) were 
excluded. 
2. Patients who were on any antibiotics in the preceding two weeks prior to giving 
the urine sample were excluded. 
3. Subjects who were unwilling to participate voluntarily were excluded.  
 
 
 43
Ethical Approval 
The study had the approval of the hospital Medical and Ethical Committee for 
research.     
Study Design 
The study was a cross-sectional descriptive study on asymptomatic bacteriuria in 
elderly diabetic women attending the Medicine clinics or Endocrine clinic in our 
centre.   
 
Sample size 
Sample size [n] for this descriptive study was calculated by using the following formula 
 [n =4pq / d²] = 4 x 18 x 82 / 8 X 8 = 5904 / 64 = 92. 
Where n=sample size, p=prevalence in %, q=100-p, d= precision. 
The desired sample size calculated with a precision of 8% was 92 older diabetic women 
assuming a prevalence of asymptomatic bacteriuria of 18% in elderly diabetic women.   
 
Study Protocol 
107 eligible subjects who satisfied inclusion criteria answered questions to 
provide the information to fill up a structured questionnaire regarding social, 
demographic and medical variables. The following features were looked into. The 
subjects were compared as regarding the presence of microvascular and 
macrovascular risk factors. They were also compared as for their physical indices 
and biochemical correlates. (The questionnaire used is attached -Appendix1). 
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They then provided a midstream clean catch sample for purpose of doing urine 
culture. Those who gave the urine culture sample subsequently went and did 
uroflowmetry. They also got their post void residual urine volume checked to look 
for any features of lower urinary tract obstruction or cystopathy.  
 
Uroflometry; 
Uroflowmetry was measured by voiding into an uroflowmeter - Urodyn 1000 
DANTEC Type 22 G02 which used an uroflow transducer from a rotating drum. 
Post void residual urine: 
Post void residue was measured by Merlin Ultrasound Model 1101 B-K medicals 
which used the following formula to calculate the residual urine volume. 
V=L.H.W.F  
Where L=length, 
H=Height, 
W=Width, 
F=factor (0.53 for bladder)   
Urine culture: 
Urine was read for growth after incubating at 32 degrees Celsius for 24 hours on 
blood and McConkey agar. The urine cultures that grew more than 10 5 colonies 
/ml were considered as asymptomatic bacteriuria. 
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Definitions:   
The following were the cut offs taken for defining the groups: 
1. Definition of diabetes mellitus:-Diabetes was assumed for any patient who was 
on oral hypoglycaemic agents /insulin or any subject fulfilling American Diabetic 
Association criteria for Diabetes mellitus20, 21 — 
The diagnosis of diabetes was confirmed on a subsequent day by measuring any 
one of the three criteria.  
Fasting > 126mg% (Fasting is defined as no calorie intake for at least 8 hours) 
Or 2 hours Postprandial glucose > 200mg% 
Or Symptoms of diabetes plus Random Blood Glucose>200mg% 
  2.  Glycaemic control: - HbA1c <7- was taken as good control 
                        
  3. Dyslipidemia:- 
       - If Cholesterol was >200mg/dl 
        Or Triglycerides was >150mg/dl 
        Or HDL was <40 mg/dl 
        Or LDL was >100 mg/dl 
 
  4.  Body mass Index: - defined as  
        a) Underweight if BMI was less than 18 kg/m2 
        b) Normal if BMI was between 19 and 24 kg/m2 
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        c) Overweight if BMI was between 25 and 29 kg/m2 
        d) Obese if BMI was more than 30 kg/m2 
 
5. Peripheral neuropathy:-  
Neuropathy was defined as per the international consensus meeting on the 
outpatient diagnosis and management of Diabetic neuropathy as “the presence 
of symptoms and/or signs of peripheral nerve dysfunction in people with diabetes 
after the exclusion of other causes” 22.  
It was taken as present If Monofilament threshold >/= 4gm, in either of the feet- If 
done by biothesiometer threshold was >/= 25 mV 
Light touch sensation was tested using 2gm, 4gm and 10 gm Semmes- 
Weinstein monofilaments over metatarsal head/ ball of the great toe (while 
testing; only mild pressure was applied so that the filament was not bent). Loss of 
sensation over 2gm was considered as peripheral neuropathy in the lower limbs. 
Loss of protective sensation in the lower limb is indicated by 10 Gms loss of 
sensation. The patient is asked to say “yes” each time he or she feels the 
filament. Failure to feel the filament at four of ten sites is 97% sensitive and 83% 
specific for identifying loss of protective sensation. This method has sufficient 
reproducibility, when used as a screening test for diabetic foot ulcerations.  
 
 Quantitative Sensory Testing  was done by using a Biothesiometer.This  
provides a quick and reliable assessment of vibration thresholds, which gives an 
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objective measure of the progress of diabetic peripheral neuropathy. A value 
above 25V was taken as evidence of neuropathy. 
However, when a biothesiometer was not available detection of impairment of 
vibration sense was done using tuning fork (128 Hz).  
 
 6. Nephropathy115:-    
-Microalbuminuria was present if the urine microalbumin was between 30 and 
300 microgm/mg of creatinine or 30- 300 mg/day in a 24 hour urine collection.  
  -macroproteinuria– If urine microalbumin >300 microgm/mg of creatinine or 24 
hour urine protein was more than 500mg/24 hours. 
        
 7. Retinopathy:- Present or absent as confirmed by an Ophthalmologist .The 
diagnosis was made in the presence of microaneurysms, dot and blot 
hemorrhages and evidence of clinically significant macular edema, or any patient 
who LASER/ intervention for retinal detachment/ vitreous hemorrhage. 
 
 8. Cardiovascular disease: - Any of the following features were taken:  
                a) Past history of acute coronary syndrome 
                b) Stable angina 
                c) History of PTCA/ Coronary artery bypass grafting 
                d) Tread Mill Test (TMT) positivity  
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9. Cerebrovascular disease: - Any of the following features: 
              a) History of transient ischemic attack/ stroke 
              b) Carotid stenosis- either carotid bruit or Doppler proven 
10. Peripheral vascular disease: - Any of the following features: 
             a) Absent peripheral pulses 
             b) Claudication pain 
             c) History of gangrene/ amputation   
11. Renovascular disease: - Any of the following features: 
              a) Renal bruit 
              b) Doppler evidence of renal artery stenosis 
12. Obstructive uropathy /cystopathy:-This was defined as per the standard 
urologic terminology of the International Continence Society guidelines 
.Abnormal post void residual urine was defined as PVR more than 10% of the 
voided volume measured by ultrasound. Abnormal uroflowmetry was defined as 
the presence of Peak urine flow less than 20 ml/sec measured by an 
uroflowmeter. 
13. Asymptomatic bacteriuria:-Defined as the presence of at least 105  colony 
forming units /ml of 1 or 2 of the same microorganism in a culture of clean voided 
midstream urine from a patient without fever or a symptoms of a urinary tract 
infection.      
 
 
 
 49
 
STATISTICAL ANALYSIS OF DATA      
 
The prevalence of asymptomatic bacteriuria was calculated. Prevalence of diabetic 
cystopathy /obstructive uropathy was calculated among those with and without 
asymptomatic bacteriuria. Analysis was done among the group with asymptomatic 
bacteriuria as compared with those without asymptomatic bacteriuria to calculate the 
relative risk, odds ratio, and 95%C.I for suspected risk factors like elevated HbA 1C, 
length of diabetes, presence of macrovascular complications, past history of urinary tract 
infection etc. Univariate analysis of individual risk factors was performed for the final 
analysis. The statistical software SPSS 16.0 for Windows was used for statistical 
calculations. 
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                               5. RESULTS     
 
A total of 107 diabetic women patients were evaluated for the prevalence of 
asymptomatic bacteriuria between October 2007 and August 2008.All were diabetics 
who attended the diabetic endocrine out patient clinic or the Medicine out patient clinics 
at the Christian Medical College Hospital (CMCH)Vellore.  All of them were evaluated for 
diabetic co morbidities and complications-both microvascular and macrovascular.Of 
these 78 patients had given urine for culture to look for asymptomatic bacteriuria. 
Among them 61 went on to do the uroflowmetry to look for evidence of obstructive 
uropathy .Only 57 completed the post void residual urine estimation which was to look 
for diabetic cystopathy. 
          
                                                     
                                             107 included for study 
           
        29 did not do urine cultures                       
        (excluded from final analysis)                                  
                     
                                         
                                  
                                   78 went on to do the urine cultures 
 
                                        
                                 61 went on to do the uroflowmetry tests  
                                                                  
           
 57 went on to do the post void residue tests 
 
Figure 3.  Flow chart showing patient recruitment   
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Table  8. Characteristics of subjects who gave urine for culture 
Patient characteristics n is either MEAN +/-SD  or 
number (%)      
Age   59.12(+/- 6.74) 
Duration of diabetes (years)  10.13(+/- 7.5) 
HbA1C  8.41(+/- 1.70) 
Fasting blood sugar <110  15(19.5%) 
Post prandial blood sugar<140  11(14.3%) 
BMI (Kg/M2)  26.10(+/- 3.85) 
Insulin use   27(34.6%) 
Past history of UTI  7(9%) 
Functionally dependent  
 
3 (3.9%) 
Past urinary catheterisation  17(21.8%) 
Past renal  stones  3(3.8%)   
Presently have urinary incontinence  17(22.1%) 
Significant urine culture  13(16.6%) 
Escherichia coli in positive urine culture     11(84%) 
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1. AGE: 
The mean age of the subjects was 59.12 years(+/- 6.742 ) with a range from 50 to 76 
years. 58% of the subjects fell within the age groups of 50-59 years,26% between the 
age groups of 60-69 and 8% were 70 years or older. All the subjects with asymptomatic 
bacteriuria were between the age groups of 50-70 years.  Figure 4 shows the age wise 
distribution of the subjects.    
 
 
  Figure 4. Age distribution of the subjects 
 
 
 
2. Duration of diabetes (years): 
 
The duration of diabetes ranged from 0.25 years to 30 years with a mean 
duration of 10.08 years (+/- 7.64) 
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3. HbA1C: 
The HbA1C ranged between 6gm% and 13gm% with a mean of 8.24gm% 
(+/- 1.56),14.3%(9 out of 63) of the subjects had a HbA1C which was <7gm% 
indicating good glycaemic control. 15.9% (10 out of 63) of the subjects had a 
poor glycaemic control with HbA1C of =/>10gm%. The breakdown of the HbA1C 
among those with asymptomatic bacteriuria is given in the table below.  
 
Table 9. Glycaemic control in relation to asymptomatic 
bacteriuria 
 
Significant urine culture HbA1c 
absent              present 
<7 gm% 
 
8(15.4%) 1(9.1%) 
7-9.99 gm% 
 
38(73.1%) 6(54.5%) 
>9.99 gm%  
 
6(11.5%) 4(36.4%) 
 
The HbA1C levels and the risk of developing ASB was not significant  
(Fisher's Exact Test =0.135).  
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4. BMI (Kg/M2): 
The BMI ranged from 16.8 to 34.2 Kg/m2.The mean BMI was 26.10 Kg/m2 (+/- 1.70).  
34 %( 25) of the subjects had a BMI between 19-25 Kg/m2. 4 %( 3) of the subjects were 
underweight.47 %( 35) of the subjects were overweight .15 %( 11) of the subjects were 
obese.   
 
5. Medication.  
6% (5) of the patients were on insulin only and 66% (51) were on oral 
hypoglycaemic agents (OHA’s) only. 28% (22) were on both OHA’s and insulin. 
There were no patients exclusively on diabetic diet. Table 10 shows the diabetic 
treatment of the screened subjects.    
 
 
Table 10. Pattern of anti diabetic medication use 
MEDICATION % 
OHA ONLY 66 
INSULIN ONLY 6 
OHA&INSULIN 28 
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6. Urinary cultures positive for asymptomatic bacteriuria: 
The prevalence of asymptomatic bacteriuria detected was 16.7% (13 out of 78).  
 
 
     
Figure 5. Prevalence of asymptomatic bacteriuria 
The commonest organism isolated was Escherichia coli among the 13 people 
with significant growth on urine culture (asymptomatic bacteriuria).Of them 
Escherichia coli was 84% (11), Proteus 8 %( 1) and Citrobacter  diversus  
8 %( 1) 
 
 
 
 
 
 
 
65, 83%
13, 17%
Absent
Present 
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Table 11.  Diabetic co morbidities and complications  
 
Dyslipidemia  26(46.2%) 
Serum creatinine  0.88(+/- 0.22) 
Normoalbuminuria(<30 mg)  25(42.4%) 
Microalbuminuria (30-300mg)  30(50.8%) 
Macroalbuminuria(>300mg)   4(6.8%) 
Nephropathy  34(57.6%) 
Peripheral neuropathy  23(31.5%) 
Autonomic neuropathy      
1(1.4%) 
Retinopathy  12(15.4%) 
Macrovascular complications  10(12.8%) 
Ischaemic heart disease  9(11.5%) 
Cerebrovascular disease  0(0%) 
Renovascular disease  0(0%) 
Peripheral vascular disease  1(1.3%) 
 
 
 
 
 
 
 
 
 57
 
 
 
 
DIABETIC COMORBIDITIES AND COMPLICATIONS 
  
 
1. Dyslipidemia: 
46.2 %( 26) had dyslipidemia 
 
2. Serum creatinine: 
The serum creatinine ranged between 0.6 to 1.9 mg/dl. The mean serum creatinine was 
0.88mg/dl (+/-.225). 
 
 3. Microvascular complications: 15.4 %( 12) had retinopathy, and 31.9% (23) had 
neuropathy.57.6% (34) had nephropathy. This is shown in the Figure 6.  
 
  Figure 6.Renal status of the subjects  
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 4. Macrovascular complications: 
The prevalence of ischaemic heart disease was 11.5 %( 9).The prevalence of peripheral 
vascular disease was 1.3 %( 1).The prevalence of renovascular disease was 0 in the 
studied population. The prevalence of cerebrovascular disease was 0 in the studied 
population. 
 
 
  Figure 7. Prevalence of macrovascular complications   
 
.          
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Table 12. Characteristics of the PVR and Uroflowmetry   
Patient characteristics n is either MEAN +/-SD  or 
number (%)      
Post void residue (PVR) < 50 ml  42(73.7%) 
Post void residue (PVR)  50-100 ml 12(21.1%)   
Post void residue (PVR) > 100 ml 3(5.3%)   
Mean Post void residue (PVR)  39.02(+/- 39.13) 
Mean peak urinary flow rate( Qmax )    22.87(+/- 10.46) 
Qmax <10ml/sec  1(1.6%) 
Qmax 10-20ml/sec 30(49.2%) 
Qmax >20ml/sec  30(49.2%)   
 
 
Uroflowmetry and PVR. 
 
The prevalence of abnormal peak urinary flow rate on uroflowmetry (Q max) was 
50.8 %( 31 out of 61).The prevalence of abnormal Q max during uroflowmetry 
among those with asymptomatic bacteriuria was 63.6% (7 out of 11). The mean 
Qmax was 22.87+/-10.46.  People with lower Q max especially < 10 ml/sec had a 
1.154 times greater risk estimate of having asymptomatic bacteriuria as 
compared with those with Qmax >20 ml/sec which was statistically significant 
(95% C.I=1.003-1.328).     
 
The prevalence of abnormal post void residue was 43.6% (24 out of 55).The 
prevalence of abnormal post void residue was 36.4% among those  with 
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asymptomatic bacteriuria (4 out of 11). The mean post void residue was 39.02 ml 
+/-39.13.There were 42 (73.7%) diabetic women with PVR less than 50 ml. There 
were 12 (21.1%) diabetic women with PVR between 50 ml-100ml and 3 (5.3%) 
diabetic women with PVR more than 100 ml. This is shown in the Figure 8    
          
 
Figure 8. Post void residual urine volume    
 
 
Prevalence of either abnormal PVR or Qmax among all the study subjects was 
64.5 %( 40 out of 62).Prevalence of either abnormal PVR or Qmax among those 
with asymptomatic bacteriuria was 60.5% (6 out of 10). 
 
 
 
 
4, 8%
37, 69%
12, 23%
<50 ML
50-100ML
>100ML
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Table 13 .Profile of subjects with asymptomatic bacteriuria 
Significant urine culture Minimum Maximum Mean Std. Deviation 
Age 53 68 59.46 5.517 
HbA1c 6 13 9.19 2.198 
Duration(years) .50 25.00 10.3462 7.08691 
Creatinine(Mg/dl) .80 1.70 .9333 .26054 
Body Mass Index 16.8 34.2 26.167 4.8331 
PVR(ML) 10 49 19.27 11.001 
Q MAX(ML/SEC) 10.10 47.50 22.3000 11.68623 
 
Valid N (listwise)     
 
 
The baseline characteristics of the people with and without asymptomatic 
bacteriuria was similar except with respect to post void urine residue (PVR) as 
seen in Table 6 .which was not statistically significant. 
(Risk estimate 0.68, 95% CI=.175-2.683)  
 
Table 14. Comparison of subjects with and without  
asymptomatic bacteriuria 
 
No ASB 
Significant urine 
culture(ASB) 
Characteristics  Mean 
Std. 
Deviation Mean 
Std. 
Deviation 
Age(Years)   59.05 6.996 59.46 5.517 
HbA1c 8.24 1.560 9.19 2.198 
Duration(years) 10.0808 7.64203 10.3462 7.08691 
Creatinine (Mg/dl) .8750 .21763 .9333 .26054 
BODY MASS 
INDEX(Kg/M2) 
26.095 3.6819 26.167 4.8331 
PVR(ML) 43.74 41.960 19.27 11.001 
Q MAX(ML/SEC) 23.0020 10.29796 22.3000 11.68623 
 
Valid N (listwise)    
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Table  15 . Risk factors for asymptomatic bacteriuria in women 
with Type 2 diabetes mellitus.         
 
Risk factors N 
 
General characteristics 
 ASB 
absent 
No(%) 
ASB 
present 
No(%) 
Odds 
Ratio 
95% 
C.I 
Age less than 60 years 
 
43 8 
Age more than 60 years 
 
22 5 
1.22 .357-
4.179 
Duration of diabetes <10 years 
 
43(81.1) 10(18.9) 
Duration of diabetes >10 years 
 
22(88) 3(12) 
.586 .146-
2.351 
UTI in the previous year (No) 
 
62(87.3) 9(12.7) 
UTI in the previous year(Yes) 
 
3(42.9) 4(57.1) 
.738 .616-
.884 
BMI (Kg/m 2) < 25 
 
24(85.7) 4(14.3) 
BMI (Kg/m 2) >/=25 
 
38(82.6) 8(17.4) 
1.263 .343-
4.656 
HbA1C   <7 
 
8(88.9  ) 1(11.1) 
HbA1C  =/>10 
 
6( 60.0 ) 4(40.0 )  
5.33 .468-
60.797 
Drugs(No Insulin use)  
 
47(92  ) 4(8 ) 
Drugs(Insulin use alone or as 
combination with OHA)  
 
18( 66 ) 9(34 ) 
5.875 1.606-
21.494 
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Table 16.  Risk factors for diabetic comorbidities  and 
complications 
 
Risk factors N 
 
 ASB 
absent 
No(%) 
ASB 
present 
No(%) 
Odds 
Ratio 
95% C.I
Dyslipidemia absent 
 
28(75.7  ) 9(24.3 ) 
Dyslipidemia present 
 
32(88.9  ) 4(11.1 ) 
2.571 .713-
9.270  
Normal Serum creatinine 
 
55(83.3  ) 11(16.7) 
Abnormal Serum creatinine  
 
 
1(50  ) 1(50) 
5.00 .290-
86.128 
Retinopathy absent 
 
43(89.6) 5(10.4) 
Retinopathy present 
 
8(66.7) 4(33.3) 
4.3 .944-
19.582 
Peripheral neuropathy absent 
 
41( 83.7 ) 8( 16.3) 
Peripheral neuropathy present 
 
19( 82.6 ) 4(17.4 ) 
1.079 .289-
4.030 
Nephropathy Absent  
 
23(92 ) 2(8) 
Nephropathy Present 
 
26(76.5 ) 8(23.5) 
3.538 .681-
18.387 
 
Microvascular complications (No)  
   
10(83.3  ) 2(16.7)  1.184 .220-
6.374   
Microvascular complications (Yes) 
 
38(80.9  ) 9(19.1)   
Macrovascular complications (No) 
 
58(86.6) 9(13.4) 4.296 1.011-
18.260 
Macrovascular complications(Yes) 
 
6(60 ) 4(40)   
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              Table 17. Risk factors  Uroflowmetry and PVR        
 
Risk factors N 
 
 ASB 
absent 
No(%) 
ASB 
present 
No(%) 
Odds 
Ratio 
95% C.I
Post void residue<50 ml 
 
31( 73.8 ) 11( 26.2 ) 
Post void residue>50 ml 
 
15( 100 ) 0( 0 ) 
Risk 
Estimate 
.738 
.616-
.884 
Normal Post void residue 
(<10% of voided volume) 
23( 76.7 ) 7( 23.3 ) 
Abnormal Post void residue (>20% 
of voided volume) 
10( 90.9 ) 1( 9.1) 
.329 .036-
3.034 
Normal Qmax(>20ml/sec) 
 
26( 86.7 ) 4(13.3 ) 
Abnormal Qmax (<10 ml/sec)   
 
1( 100 ) 0(0 ) 
Risk 
Estimate 
1.154 
1.003-
1.328 
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Diabetics with macrovascular complications had 4.2 higher risk of developing 
ASB as compared to patients without macrovascular complications of diabetes 
which was statistically significant (95%CI 1.011-18.260). 
Subjects taking insulin had a 5.87 times the odds of developing ASB as 
compared to those without ASB. This was statistically significant ((95% CI = 1.61-
21.5).   
Patients with HbA1c >10gm% had 5.33 times higher risk of having ASB than 
patients with HbA1c <7gm% .This figure was however not statistically significant 
(95%C.I =0.46-60.797). 
 
Patients with duration of diabetes >10 years had a 2.37 times higher risk of 
having ASB than patients with a duration of diabetes <5 years. This figure was 
however not statistically significant (95%, C.I =0.447-12.571). 
 
There was no significant association for asymptomatic bacteriuria with age, 
duration of diabetes, HbA1c, body mass index , lipid status, creatinine values, 
nephropathy, neuropathy, microvascular complications, peripheral vascular 
complications, heart disease, past history of urinary tract infections, past 
catheterization , urinary incontinence, past renal stones, peak urinary flow rates 
and post void residue urine.    
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                            6. DISCUSSION          
 
.  
 
A total of 107 older diabetic women were screened for the study of which 78 
followed up to do the urine cultures.13 patient’s had significant urine cultures with 
colony counts greater than greater than 105  colonies/ml. The overall prevalence 
of asymptomatic bacteriuria (ASB) was 16.7 %,( 13 out of 78). This prevalence of 
ASB was similar to what was described by Bonadio et al in 2004132.  
Geerlings et al in 2000 reported a prevalence of 26%.55.Our study was thus 
similar to earlier studies of diabetic women with the prevalence ranging from 8–
26% 4, 12,129,130.    
   
Diabetic subjects taking insulin had   5.87 times higher odds of developing ASB 
as compared to those not on insulin. This was statistically significant ((95% CI = 
1.61-21.5). This finding is similar to what was found by Bokyo et al in 2005 51. 
Women taking insulin were mainly at higher risk, possibly because of more 
severe diabetes since the use of insulin may be a marker of disease severity142.  
 
Subjects with macrovascular complications had 4.2 higher odds of developing 
ASB as compared to diabetic women without macrovascular complications. This 
result was statistically significant (95%CI 1.011-18.260).  
 Prevalence of abnormal Q max during uroflowmetry among those with 
asymptomatic bacteriuria was 70% (7 out of 10). Diabetic subjects with a lower 
peak urinary flow rates (Q max)  especially < 10 ml/sec had a 1.154 times greater 
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risk estimate of having asymptomatic bacteriuria as compared with those with 
Qmax >20 ml/sec.This result  was statistically significant (95% C.I=1.003-1.328).     
This could probably be indicative of a greater amount of bladder dysfunction 
which is a long term complication of asymptomatic bacteriuria and diabetes.   
 
Diabetic subjects with retinopathy had 4.3 times the odds of developing ASB as 
compared to subjects without retinopathy. This figure was almost reaching 
statistical significance (95% C.I =0.944-19.58). 
Diabetic subjects with dyslipidemia had a 2.5 times greater risk of developing 
ASB as compared to diabetics with no dyslipidemia.This was however not 
statistically significant. (95% C.I =0.46-60.797). 
Diabetic subjects with abnormal serum creatinine had a 2.5 times greater risk for 
developing ASB as compared to diabetics with normal serum creatinine.This  
was however not statistically significant. (95% C.I =0.29-86.128).This was unlike 
what Ishay A et al described in 2006 who found serum creatinine as an 
independent risk factor for ASB 143 . 
Diabetic patients with Nephropathy had 3.5 times risk of getting ASB as 
compared with patients who had no nephropathy. However this figure was not 
statistically significant (95% C.I =.681-18.387). 
Some studies have shown that a longer duration of diabetes increases the risk of 
developing ASB 50 while others could not confirm this notion134-136. In our study 
duration of diabetes greater than 10 years as compared to those with diabetes 
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duration less than 5 years showed a 2.3 times greater risk estimate which was 
not statistically significant(95% CI=0.447-12.571). 
There was a 5.33 times higher odds of patients with HbA1c >10gm% as compared 
to patients with a HbA1c <7gm% having asymptomatic bacteriuria which was not 
statistically significant. (95% C.I =0.46-60.797).This is similar to most studies4, 12, 
55,129, but not all132, which have found no relationship between glycaemic control 
and ASB.      
A variety of potential ASB risk factors have been assessed in previous, mostly 
small-scale studies with inconsistent results. In these studies there was no 
significant association for ASB with microvascular complications, vascular 
complications, heart disease, past history of urinary tract infection, past 
catheterization, urinary incontinence and renal stones.  
Though  age is a well known risk factor for bacteriuria in women without 
diabetes133 and some studies have shown age as the most important risk factor 
for ASB in Type 2 diabetes mellitus55, age had no significant relationship with 
ASB in our study (Odds=1.22 with 95% CI =0.36-4.18).      
In our study Body mass index (BMI) was not associated with any significant 
association with ASB (Odds ratio=1.26 with 95% CI was 0.34-4.65) .However 
Geerling et al 55 has proposed a low BMI as a risk factor for ASB. 
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Chronic complications such as nephropathy and neuropathy have been 
associated with ASB in type 1 but not with type 2 diabetic patients11, 129 a pattern 
that also holds for longer diabetes duration11. In some of these studies, a small 
sample size and restricted number of variables limit the conclusions that could be 
drawn. We found no significant association between the occurrence of 
nephropathy or neuropathy and development of ASB. 
 
The prevalence of abnormal post void residue was 36.4% among those with 
asymptomatic bacteriuria (4 out of 11).There was no significant correlation (Odds 
ratio=0.329) among the presence of bladder residue and ASB. As found in other 
studies the presence of peripheral neuropathy did not correlate significantly with 
bladder residue, and ASB55,80.      
We diagnosed ASB using a single urine culture as it was the most practical and 
cost-effective way to screen patients routinely. Although the definition of ASB in 
women conventionally requires two urine cultures taken >24 hours apart, this 
practice does not improve specificity compared with a single specimen 
collection98. 
The commonest organism isolated was Escherichia coli (84%) among the 13 
women with significant growth on urine culture (asymptomatic bacteriuria).The 
organism  was similar to most other studies 131,132 .The other organisms were 
Proteus 8%(1) and Citrobacter diversus 8 %(1).    
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As there is  a higher risk of and ASB  and acute symptomatic urinary tract 
infections(UTIs) among post menopausal women51 with diabetes  further 
adequately powered multicentre intervention studies are, therefore, needed to 
determine whether active screening for, and prompt antibiotic treatment of, ASB 
in diabetes is effective to reduce the risk of morbidity from UTIs.      
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                        7. CONCLUSION 
 
 
1. Asymtomatic bacteriuria is a common finding in adults and diabetic women have a 
higher prevalence of this condition.    
2. In our study the prevalence of asymptomatic bacteriuria was 16.7%. 
3. There was no significant association between the occurrence of post voidal residual 
urine (PVR) and asymptomatic bacteriuria.  
4. There was no association between asymptomatic bacteriuria and the presence of 
peripheral neuropathy. 
 5. Presence of macrovascular complications and the usage of insulin had a significantly 
increased risk of having asymptomatic bacteriuria.     
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                       9. LIMITATIONS 
 
1. One of the drawbacks of the study was the small sample size which would limit 
the statistical significance of individual risk factors. Multivariate analysis for 
comparing significant risk factors was not done in view of the small sample size. 
2. Only a single urine culture was used in diagnosing asymptomatic bacteriuria due 
to financial constraints. 
3. Community studies would be required with representative women to fully 
generalize the results to the rest of the community population as the sample 
population was mainly diabetic women who presented to this tertiary care 
teaching hospital from the Vellore district of Tamil Nadu.  
4. The exact onset of Diabetes cannot be easily determined, since symptoms may 
remain occult for years130. Error in estimating diabetes duration due to this 
problem is likely to underestimate the associated effects.  
5.  Due to ethical issues we did not do invasive cystometrogram based pressure 
flow studies of the people who had significantly abnormal uroflowmetry and post 
void residual urine abnormal results which could help truly confirm obstructive 
uropathy and true detrusor dysfunction.   
6. Presence of autonomic neuropathy other than postural drop in blood pressure 
was not measured. 
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                            ANNEXURES 1 
 
                               QUESTIONNAIRE   
 
1.      Name:                                                                                                    2.      Age: 
 
3.   Address : 
 
 
4.     Telephone no:                                                5. Hospital No:    
                      
6. Weight in Kg:                   7 .Height in Meters:    8.Body mass index: 
 
9.      Are you functionally independent: 
YES      NO 
 
 
10.  Have you had urinary tract infection in 
the  past: YES      NO 
 
11.  Have you had urinary catheterization in 
the     past:   YES      NO 
 
12.  Have you had  renal stones in the past: 
YES      NO 
 
 
13.  Have you had urinary incontinence: 
YES      NO 
 
 
 
 
 
ABOUT DIABETES: - circle the appropriate response 
                                                                                   
14. TYPE OF DIABETES :      TYPE 
1    
TYPE 
2 
 
15. DURATION OF DIABETES IN YEARS:  
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MICROVASCULAR & MACROVASCULAR COMPLICATIONS:-circle the 
appropriate response      
16. MEDICATIONS:       OHA   INSULIN 
17.PERPHERAL 
NEUROPATHY: 
paresthesia sensory 
loss 
motor 
neuropathy 
sensorimotor 
18.AUTONOMIC NEUROPATHY: postural drop in blood pressure 
19.DIABETIC 
RETINOPATHY : 
 
 
Non 
Proliferative 
DR 
Proliferati
ve DR  
 
(laser 
Therapy 
/CSME) 
(Vitreous 
haemmorha
ge/Retinal 
detachment 
)            
20.ISCHAEMIC 
HEART DISEASE  
 
Stable 
angina 
old MI / 
ACS 
TMT  
positivity  
PTCA 
/CABG 
21.CEREBROVASCUL
AR DISEASE 
TIA  CVA  carotid 
stenosis 
Bruit/Doppl
er 
abnormality 
22.PERIPHERAL 
VASCULAR DISEASE 
 
absent 
pulses  
 
claudicati
on pain  
gangrene  amputation 
23.RENOVASCULAR 
 
Bruit  Doppler   
24. DYSLIPIDEMIA 
PRESENT  ABSENT 
If 
present: 
Treated  
(YES/NO
) 
 
 
INVESTIGATIONS:- 
25. FBS:  
 
26. PPBS:  
 
27. HbA1c:  
 
28. S.CREATININE:  
 
29.TWENTY FOUR 
HOUR URINE PROTEIN:   
           
 MICROALBUMINURIA: 
32. URINE CULTURE:  
 
33.POSTVOIDRESIDUE     
(PVR)URINE: 
 
34.UROFLOWMETRY:  Qmax:                            Average flow rate: 
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                                               ABSTRACT 
 
 
Title: Asymptomatic bacteriuria in older diabetic women . 
 
Department: Department of Medicine Unit 3 and Geriatrics, 
                      Christian Medical College Hospital, Vellore - 632004. 
 
Name of the candidate:  Dr. Sushil Thomas Alexander, 
                                         Postgraduate Student, 
                                         General Medicine. 
 
Degree: MD (General Medicine) 
 
Name of the Guide: Dr. K. Prasad Mathews  
                                  Professor of Medicine, 
                                  Department of Medicine Unit 3 and Geriatrics, 
                                  Christian Medical College Hospital, Vellore. 
 
Objectives of the study: 
To study the prevalence and clinical and laboratory predictors of asymptomatic 
bacteriuria in  older women with Type 2 diabetes. 
Methods: 
A total of 107 diabetic women ,50 years and above ,who  attended the Medicine 
and Endocrinology outpatient clinic were included in the study .We evaluated risk 
factors by interviewing and screening for the presence of asymptomatic 
bacteriuria in these women .At least 1 uncontaminated urine sample was taken 
for analysis. Asymptomatic bacteriuria was defined as at least 105 colony forming 
units /ml of 1 or 2 bacterial species from the culture of the midstream clean catch 
sample from individuals without symptoms of urinary tract infection. 
Results: 
The prevalence of asymptomatic bacteriuria was 16.7% in Type 2 diabetic 
women .Risk factors for asymptomatic bacteriuria in Type 2 diabetic women 
included presence of macrovascular complications ,the use of insulin and the 
presence of lower peak urinary flow rates. No significant association was 
associated with age, BMI, duration of diabetes, HbA1c, dyslipidemia, 
nephropathy, neuropathy and microvascular diabetic complications. 
Conclusion 
Asymptomatic bacteriuria is a commonly prevalent condition in older women with 
Type 2 diabetes mellitus .The most common organism cultured was Escherichia 
coli.    
 
  
 
 
 
